The NAD+ 1000mg & Retatrutide: The UK Advance in Cellular Health
Emerging findings from the UK are generating considerable interest surrounding the potential synergy of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This unique approach aims to target multiple facets of metabolic disorder, potentially offering a subs